AAOS, OREF partner to drive funding for biologic, total joint replacement research

Alan Condon -   Print  |

The American Academy of Orthopaedic Surgeons on May 7 teamed with the Orthopaedic Research and Education Foundation to raise money for clinical researchers.

Funding will go toward biologic research for orthopedic diseases, with a special focus on platelet-rich plasma and growth factor injections for rotator cuff tears and knee osteoarthritis.

Research evaluating the effect of tobacco, vaping and marijuana use on postoperative outcomes for total joint replacement and the effectiveness of antibiotic bone cement for prevention of periprosthetic joint infections will also be prioritized.

AAOS made the first investment to kickstart the fund.

More articles on orthopedics:
Geoff Martha, Kevin Lobo & more: 5 CEOs to know in the spine industry
Wright Medical inches toward sale, makes pay cuts due to pandemic: 5 updates
How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson's shares over the last month

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers